Liver Biopsy Articles & Analysis
3 articles found
Abstract Background and aim: Nonalcoholic fatty liver disease (NAFLD) patients with significant hepatic fibrosis (stage ≥ 2) are at increased risk of liver-related morbidity and are candidates for pharmacologic therapies. In this study, we compared the diagnostic accuracy of MEFIB (the combination of magnetic resonance elastography [MRE] and FIB-4) and FAST ...
As clinical researchers, regulators and pharmaceutical partners pursue noninvasive biomarkers to replace liver biopsy, links to adverse long-term outcomes in fatty liver disease populations are needed. This important study of MRE and long term cardiovascular outcomes adds a new dimension to the growing body of literature that elevated ...
Nonalcoholic fatty liver disease (NAFLD) is associated with obesity but also found in non-obese individuals. ...